These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23908381)

  • 1. Statistical power in three-arm cluster randomized trials.
    Liu XS
    Eval Health Prof; 2014 Dec; 37(4):470-87. PubMed ID: 23908381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size calculation for treatment effects in randomized trials with fixed cluster sizes and heterogeneous intraclass correlations and variances.
    Candel MJ; van Breukelen GJ
    Stat Methods Med Res; 2015 Oct; 24(5):557-73. PubMed ID: 25519890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation.
    van Breukelen GJ; Candel MJ
    Stat Methods Med Res; 2015 Oct; 24(5):540-56. PubMed ID: 21937473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cluster size variability on statistical power in cluster-randomized trials.
    Lauer SA; Kleinman KP; Reich NG
    PLoS One; 2015; 10(4):e0119074. PubMed ID: 25830416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and analysis of clinical trials with clustering effects due to treatment.
    Roberts C; Roberts SA
    Clin Trials; 2005; 2(2):152-62. PubMed ID: 16279137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing homogeneity of proportion ratios for stratified correlated bilateral data in two-arm randomized clinical trials.
    Pei Y; Tian GL; Tang ML
    Stat Med; 2014 Nov; 33(25):4370-86. PubMed ID: 24974954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Likelihood inference on the relative risk in split-cluster designs.
    Shoukri MM; Colak D; Donner A
    Clin Trials; 2011 Feb; 8(1):37-47. PubMed ID: 21335588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient treatment allocation in two-way nested designs.
    Lemme F; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):494-512. PubMed ID: 24030312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A note on statistical power in multi-site randomized trials with multiple treatments at each site.
    Liu XS
    Br J Math Stat Psychol; 2014 May; 67(2):231-47. PubMed ID: 23710937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of cluster randomized trials.
    Campbell MJ
    J Comp Eff Res; 2014 May; 3(3):271-81. PubMed ID: 24969154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of heterogeneous variance on efficiency and power of cluster randomized trials with a balanced 2 × 2 factorial design.
    Lemme F; van Breukelen GJ; Candel MJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):574-93. PubMed ID: 25911332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative efficiency and sample size for cluster randomized trials with variable cluster sizes.
    You Z; Williams OD; Aban I; Kabagambe EK; Tiwari HK; Cutter G
    Clin Trials; 2011 Feb; 8(1):27-36. PubMed ID: 21163852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.
    Kombrink K; Munk A; Friede T
    Stat Med; 2013 Aug; 32(18):3055-66. PubMed ID: 23508697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test non-inferiority and sample size determination based on the odds ratio under a cluster randomized trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2011 Jan; 21(1):94-110. PubMed ID: 21191857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis.
    White IR; Thomas J
    Clin Trials; 2005; 2(2):141-51. PubMed ID: 16279136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model mis-specification and overestimation of the intraclass correlation coefficient in cluster randomized trials.
    Giraudeau B
    Stat Med; 2006 Mar; 25(6):957-64. PubMed ID: 15977300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E; Tango T
    J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.